Patient Navigator Intervention for Diabetic Retinopathy

Completed · Not applicable

Conditions studied: Diabetic Retinopathy, Diabetic Blindness

In brief

This is a pilot study of a patient navigator intervention for people living with diabetes and at high risk of diabetic blindness. The investigators are assessing the feasibility and acceptability of the intervention in preparation for a clinical trial.

Key facts

Study ID

NCT05188703

Run by

Yale University

People needed

35

Starts

2022-07-25

Expected to finish

2024-09-19

Last updated by the study team

2026-03-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults aged 18 and over
• Diagnosis of diabetes and record of diagnosis in YNHHS EPIC
• English-speaking
• No documented eye examination within 1 year of study enrollment
• High risk for diabetic retinopathy based on risk calculator evaluation

You may not qualify if…

• Documented eye exam in the past year
• Not high risk for diabetic retinopathy
• Diabetes diagnosis not recorded in EPIC

Where it is running

• Yale School of Medicine — New Haven, Connecticut, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.